Cargando…
Knockdown of MEF2D inhibits the development and progression of B-cell acute lymphoblastic leukemia
BACKGROUND: Myocyte enhancer factor 2D (MEF2D) is involved in the progression of various malignant tumors. However, its impact on B-cell acute lymphoblastic leukemia (B-ALL) has not been elucidated. METHODS: In this study, the expression level of MEF2D in B-ALL patients was validated through the Gen...
Autores principales: | Chang, Ning, Feng, Jianhua, Liao, Peiyun, Hu, Yuxing, Li, Meifang, He, Yanjie, Li, Yuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007885/ https://www.ncbi.nlm.nih.gov/pubmed/36915581 http://dx.doi.org/10.21037/tcr-22-1778 |
Ejemplares similares
-
Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia
por: Wang, Hao, et al.
Publicado: (2023) -
Characterization of a novel MEF2D-BCL9 fusion-positive acute lymphoblastic leukemia cell line
por: van Outersterp, Inge, et al.
Publicado: (2023) -
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
por: Gu, Zhaohui, et al.
Publicado: (2016) -
Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion
por: Ohki, Kentaro, et al.
Publicado: (2019) -
Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms
por: Chen, Jianyu, et al.
Publicado: (2021)